Relay Therapeutics (RLAY) Operating Income (2020 - 2025)
Historic Operating Income for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to -$80.4 million.
- Relay Therapeutics' Operating Income rose 1658.0% to -$80.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$327.1 million, marking a year-over-year increase of 1385.33%. This contributed to the annual value of -$372.5 million for FY2024, which is 14.26% up from last year.
- Latest data reveals that Relay Therapeutics reported Operating Income of -$80.4 million as of Q3 2025, which was up 1658.0% from -$76.8 million recorded in Q2 2025.
- In the past 5 years, Relay Therapeutics' Operating Income registered a high of -$42.4 million during Q1 2021, and its lowest value of -$193.6 million during Q2 2021.
- Over the past 5 years, Relay Therapeutics' median Operating Income value was -$84.9 million (recorded in 2025), while the average stood at -$86.9 million.
- Per our database at Business Quant, Relay Therapeutics' Operating Income crashed by 59836.57% in 2021 and then skyrocketed by 5980.42% in 2022.
- Over the past 5 years, Relay Therapeutics' Operating Income (Quarter) stood at -$67.7 million in 2021, then dropped by 7.57% to -$72.9 million in 2022, then fell by 26.55% to -$92.2 million in 2023, then grew by 7.83% to -$85.0 million in 2024, then increased by 5.4% to -$80.4 million in 2025.
- Its Operating Income was -$80.4 million in Q3 2025, compared to -$76.8 million in Q2 2025 and -$84.9 million in Q1 2025.